• <em>CIC de novo</em> loss of function variants contribute to cerebral folate deficiency by downregulating <em>FOLR1</em> expression
• A child with 18q- syndrome and cerebellar astrocytoma
• A preliminary study of sonographic grading of fetal intracardiac echogenic foci: feasibility, reliability and association with aneuploidy
• Abnormal distribution of aquaporin-5 water channel protein in salivary glands from Sjögren's syndrome patients
• Accurate detection of changes in disease activity in primary Sjögren's syndrome by the European League Against Rheumatism Sjögren's Syndrome Disease Activity Index
• Anhedonia in the psychosis risk syndrome: associations with social impairment and basal orbitofrontal cortical activity
• Ankylosing spondylitis with primary Sjögren's syndrome: the first two case-reports
• Anomalies of the forebrain with radial limb defects: Garcia-Lurie-Steinfeld syndrome?
• Aquaporins in primary Sjögren's syndrome: comment on the articles by Steinfeld et al
• Association Between Baseline Therapy and Flare Reduction in Mepolizumab-Treated Patients With Hypereosinophilic Syndrome
• Atresia of the left atrioventricular valve associated with corrected transposition of the great vessels. A cause of the Eisenmenger syndrome
• Big prolactin 60 kDa is overexpressed in salivary glandular epithelial cells from patients with Sjögren's syndrome
• Bone marrow transplantation in Maroteaux-Lamy syndrome (MPS type 6): status 40 months after BMT
• CASPR2 autoimmunity in children expanding to mild encephalopathy with hypertension
• Cerebral folate deficiency: a neurometabolic syndrome?
• Characterization of disease flares and impact of mepolizumab in patients with hypereosinophilic syndrome
• Chronic eosinophilic pneumonia (CEP) as a presenting feature of Churg-Strauss syndrome (CSS)
• Chronic eosinophilic pneumonia followed by Churg-Strauss syndrome
• Clinical Profile and Treatment in Hypereosinophilic Syndrome Variants: A Pragmatic Review
• Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients
• D-mannose and N-acetylglucosamine moieties and their respective binding sites in salivary glands of Sjögren's syndrome
• Distribution and roles of aquaporins in salivary glands
• Distribution of salivary aquaporin-5 in Sjögren's syndrome
• Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial
• Efficacy of community-based second trimester genetic ultrasonography in detecting the chromosomally abnormal fetus
• Elucidation of the phenotypic spectrum and genetic landscape in primary and secondary microcephaly
• Epidemic and classic Kaposi's sarcoma of the feet. A comparative study
• Epratuzumab (humanised anti-CD22 antibody) in autoimmune diseases
• Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study
• EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide
• EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome
• Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis
• Expression of calcium-sensing receptor in human minor salivary glands
• Failure to detect human papillomavirus in primary Sjögren's syndrome
• Fetal intracardiac echogenic foci: current understanding and clinical significance
• From DREAM to REALITI-A and beyond: Mepolizumab for the treatment of eosinophil-driven diseases
• HES and EGPA: Two Sides of the Same Coin
• Holoprosencephaly and limb reduction defects: a consideration of Steinfeld syndrome and related conditions
• Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS)
• Infliximab in patients with primary Sjögren's syndrome: a pilot study
• Infliximab in primary Sjögren's syndrome: one-year followup
• Intentions and outcomes in the radiotherapeutic management of epidemic Kaposi's sarcoma
• Justification of the Subcutaneous Mepolizumab Dose of 300 mg in Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome
• Labeled neoglycoproteins and human lectins as diagnostic and potential functional markers in salivary glands of patients with Sjögren's syndrome
• Long-Term Clinical Outcomes of High-Dose Mepolizumab Treatment for Hypereosinophilic Syndrome
• Mechanical parameters determining pharyngeal collapsibility in patients with sleep apnea
• Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis
• Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5
• Mepolizumab therapy improves the most bothersome symptoms in patients with hypereosinophilic syndrome
• Microform holoprosencephaly with bilateral congenital elbow dislocation; increasing the phenotypic spectrum of Steinfeld syndrome
• Modified aquaporin 5 expression and distribution in submandibular glands from NOD mice displaying autoimmune exocrinopathy
• New approaches to the treatment of Sjögren's syndrome: soon beyond symptomatic relief?
• Non-fluorescent and non-heterochromatic Y chromosome in 45, X 46,XY mosaicism
• Notice of retraction of two articles (“Infliximab in patients with primary Sjögren’s syndrome: a pilot study” and “Infliximab in patients with primary Sjögren’s syndrome: one-year followup”)
• Performance of the preliminary classification criteria for cryoglobulinaemic vasculitis and clinical manifestations in hepatitis C virus-unrelated cryoglobulinaemic vasculitis
• Pharmacogenetic investigation of efficacy response to mepolizumab in eosinophilic granulomatosis with polyangiitis
• Pontocerebellar Hypoplasia: a Pattern Recognition Approach
• Preliminary classification criteria for the cryoglobulinaemic vasculitis
• Prenatal diagnosis of Williams syndrome based on ultrasound signs
• Preoperative clinical symptomatology and stroke burden in pediatric moyamoya angiopathy: Defining associated risk variables
• Prevalence of Eosinophilic Granulomatosis With Polyangiitis and Associated Health Care Utilization Among Patients With Concomitant Asthma in US Commercial Claims Database
• Primary Sjögren's syndrome associated with pneumatosis cystoides coli
• Prolactin up-regulates cathepsin B and D expression in minor salivary glands of patients with Sjögren's syndrome
• Pyogenic arthritis caused by streptococcus equisimilis (group-C streptococcus) in a patient with AIDS
• Reply
• Response to a case report: Idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab
• Reversible pancytopenia and immunodeficiency in a patient with hereditary folate malabsorption
• Revisiting the NIH Taskforce on the Research needs of Eosinophil-Associated Diseases (RE-TREAD)
• Rheumatic manifestations due to human parvovirus B19. A report of four cases
• Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study
• Sanfilippo syndrome type C: mutation spectrum in the heparan sulfate acetyl-CoA: alpha-glucosaminide N-acetyltransferase (HGSNAT) gene
• Severe sensory neuronopathy responsive to infliximab in primary Sjögren's syndrome
• Severely altered guanidino compound levels, disturbed body weight homeostasis and impaired fertility in a mouse model of guanidinoacetate N-methyltransferase (GAMT) deficiency
• Sialic acid residues in the labial salivary glands from Sjögren's syndrome patients
• Single-molecule visualization of human BLM helicase as it acts upon double- and single-stranded DNA substrates
• Spinal cord injury with central cord syndrome from surfing
• Steinfeld syndrome: Further delineation
• Steinfeld syndrome: report of a second family and further delineation of a rare autosomal dominant disorder
• Structure of sulfamidase provides insight into the molecular pathology of mucopolysaccharidosis IIIA
• Survival among children with "Lethal" congenital contracture syndrome 11 caused by novel mutations in the gliomedin gene (GLDN)
• Symptom assessment in hypereosinophilic syndrome: Toward development of a patient-reported outcomes tool
• The increasing incidence and prevalence of hypereosinophilic syndrome in the United Kingdom
• The prognostic significance of residual pigmentation following radiotherapy of epidemic Kaposi's sarcoma
• The rheumatology and physical medicine department
• The syndrome of peripheral arterial insufficiency with partial occlusion of the iliac artery; a study of nine cases
• Treatment with infliximab restores normal aquaporin 5 distribution in minor salivary glands of patients with Sjögren's syndrome
• Twelve new patients with 13q deletion syndrome: genotype-phenotype analyses in progress
• Usefulness of mouse models to study the pathogenesis of Sjögren's syndrome
• VACTERL-hydrocephaly, DK-phocomelia, and cerebro-cardio-radio-reno-rectal community
• Vascular ring in infancy
• Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial
• Zidovudine in primary Sjögren's syndrome